Mga Batayang Estadistika
| CIK | 1000683 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Blonder Tongue Laboratories, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-14120 BLONDER TONGUE LABORATORIES, INC. (Exact name of registrant as spec |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022, OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM to Commission file number: 1-14120 BLONDE |
|
| April 17, 2023 |
Subsidiaries of Blonder Tongue Exhibit 21 List of Subsidiaries of Blonder Tongue Laboratories, Inc. 1. Blonder Tongue Far East, LLC 2. R. L. Drake Holdings, LLC |
|
| April 17, 2023 |
Exhibit 4.2 Blonder Tongue Laboratories, Inc. DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description summarizes the material terms and provisions of our common stock, which is registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (and is the only class of our securities that is |
|
| April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022, OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM to Commission file number: 1-14120 BLONDER TONGUE LABORATORIE |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 001-14120 CUSIP NUMBER (Check one): ☒ Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2022 ¨ |
|
| March 1, 2023 |
BLONDER TONGUE ANNOUNCES DEATH OF SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER ERIC SKOLNIK Exhibit 99.1 BLONDER TONGUE ANNOUNCES DEATH OF SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER ERIC SKOLNIK Old Bridge, N.J. – February 23, 2023 – It is with great sadness that Blonder Tongue Laboratories, Inc. (OTCQB: BDRL) Board of Directors announce the death of Senior Vice President and Chief Financial Officer, Eric S. Skolnik. He was 58. “Eric was a most trusted friend and business colleagu |
|
| March 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2023 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 001-14120 52-1611421 (State or other jurisdiction of incorporation) |
|
| February 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2023 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 001-14120 52-1611421 (State or other jurisdiction of incorporation) |
|
| January 23, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Departure of CEO Reappoints Robert J Palle to Chief Executive Officer and President OLD BRIDGE, New Jersey—January 23, 2023—Blonder Tongue Laboratories, Inc. (OTCQB: BDRL) (the “Company”) announced that Edward R. “Ted” Grauch has resigned as Chief Executive Officer and President effective March 18, 2023. Mr. Grauch has held these roles s |
|
| January 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 001-14120 52-1611421 (State or other jurisdiction of incorporation) |
|
| January 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| January 6, 2023 |
Exhibit 10.1 BLONDER TONGUE EXECUTIVE DEFERRED COMPENSATION AGREEMENT THIS DEFERRED COMPENSATION AGREEMENT (?Agreement?) is made as of this 30th day of December, 2022 (the ?Effective Date?), by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the ?Company?), and Edward R. Grauch (the ?Executive?). WITNESSETH: WHEREAS, the Company and the Executive desire to defer payment of c |
|
| November 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| November 4, 2022 |
Blonder Tongue Reports Third Quarter and Nine Months 2022 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Third Quarter and Nine Months 2022 Results OLD BRIDGE, NJ / November 4, 2022 / Blonder Tongue Laboratories, Inc. (OTCQB: BDRL) announced its sales and results for the third quarter and nine months ended September 30, 2022. Blonder Tongue Laboratories, Inc. net sales increased $1,090,000 or 26.1% to $5,262,000 for the third quarter of 2022 |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022. OR ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LA |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| November 3, 2022 |
Fourteenth Amendment to Loan Agreement, dated October 28, 2022. Exhibit 10.1 FOURTEENTH AMENDMENT TO LOAN AGREEMENT This FOURTEENTH AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made as of the 28th day of October, 2022, by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted ass |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| October 31, 2022 |
Thirteenth Amendment to Loan Agreement, dated October 25, 2022 Exhibit 10.1 THIRTEENTH AMENDMENT TO LOAN AGREEMENT This THIRTEENTH AMENDMENT TO LOAN AGREEMENT (this ?Amendment?) is made as of the 25th day of October, 2022, by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted ass |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022. OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LABORA |
|
| July 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commi |
|
| July 6, 2022 |
Twelfth Amendment to Loan Agreement, dated July 1, 2022 Exhibit 10.1 TWELFTH AMENDMENT TO LOAN AGREEMENT This TWELFTH AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made as of the 1 day of July, 2022, by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, ?Borro |
|
| June 28, 2022 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED COMMON STOCK The NYSE American LLC (the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove the entire class of the common stock ("'Common Stock") of Blonder Tongue Laboratories Inc (the 'Company') from listing and registration on the Exchange at the opening of business on July 11, 2022, pursuant to the provisions of Rule 12d2-2(b) because, in the opinion of the Exchange, the Common Stock is no longer suitable for continued listing and trading on the Exchange. |
|
| June 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| June 24, 2022 |
Blonder Tongue Reports Delisting, Will Trade on OTCQB Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Delisting, Will Trade on OTCQB OLD BRIDGE, NJ / June 24, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) today announced its delisting from the NYSE American and commencement of trading on the OTCQB. As previously disclosed, Blonder Tongue Laboratories, Inc. (the ?Company?) received written notification from NYSE American LLC |
|
| June 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| June 15, 2022 |
Eleventh Amendment to Loan Agreement, dated June 14, 2022 Exhibit 10.1 ELEVENTH AMENDMENT TO LOAN AGREEMENT This ELEVENTH AMENDMENT TO LOAN AGREEMENT (this ?Amendment?) is made as of the 14 day of June, 2022, by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, ?Bo |
|
| June 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commi |
|
| June 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commi |
|
| May 31, 2022 |
Conflict Minerals Report of the Company EX-1.01 2 ea160753ex10-1blondertongue.htm CONFLICT MINERALS REPORT OF THE COMPANY Exhibit 1.01 Blonder Tongue Laboratories, Inc. Conflict Minerals Report For The Year Ended December 31, 2021 This is the Conflict Minerals Report (“Report”) of Blonder Tongue Laboratories, Inc., a Delaware corporation, for the year ended December 31, 2021, which is presented to comply with Rule 13p-1 under the Securi |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized disclosure report Blonder Tongue Laboratories, Inc. (Exact name of Registrant as specified in its Charter) 1-14120 Commission file number Delaware 52-1611421 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification no.) One Jake Brown Road, Old Bridge, NJ 08857 (Address |
|
| May 26, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commi |
|
| May 24, 2022 |
DEFA14A 1 ea160503-defa14ablonder.htm DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for |
|
| May 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission File |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission File |
|
| May 11, 2022 |
DEFA14A 1 ea159779-defa14ablonder.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Comm |
|
| May 6, 2022 |
Blonder Tongue Reports First Quarter 2022 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports First Quarter 2022 Results OLD BRIDGE, NJ / May 6, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the first quarter ended March 31, 2022. Blonder Tongue Laboratories, Inc. net sales increased $90,000 or 2.8% to $3,341,000 for the first quarter of 2022 from $3,251,000 for the comparable per |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022. OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LABOR |
|
| May 6, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commis |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commis |
|
| May 5, 2022 |
Tenth Amendment to Loan Agreement, dated May 5, 2022. Exhibit 10.1 TENTH AMENDMENT TO LOAN AGREEMENT This TENTH AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made this as of the 5th day of May, 2022, and shall be retroactively effective as of January 1, 2022, by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporati |
|
| April 22, 2022 |
DEF 14A 1 ea158613-def14ablondertong.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for U |
|
| April 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| April 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| April 8, 2022 |
Ninth Amendment to Loan Agreement, dated April 5, 2022. Exhibit 10.1 NINTH AMENDMENT TO LOAN AGREEMENT This NINTH AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made this as of the 5th day of April, 2022 by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, ?Bo |
|
| March 31, 2022 |
Subsidiaries of Blonder Tongue EXHIBIT 21 List of Subsidiaries of Blonder Tongue Laboratories, Inc. 1. Blonder Tongue Far East, LLC 2. R. L. Drake Holdings, LLC |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021, OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM to Commission file number: 1-14120 BLONDER TONGUE LABORATORIE |
|
| March 31, 2022 |
Blonder Tongue Reports Year End and Fourth Quarter 2021 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Year End and Fourth Quarter 2021 Results OLD BRIDGE, NJ / March 31, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the fourth quarter and year ended December 31, 2021. Commenting on the Company?s year end and fourth quarter results, Chief Executive Officer Ted Grauch noted, ?Although the C |
|
| March 31, 2022 |
EXHIBIT 4.2 Blonder Tongue Laboratories, Inc. DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description summarizes the material terms and provisions of our common stock, which is registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (and is the only class of our securities that is |
|
| March 31, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| March 14, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| March 14, 2022 |
Blonder Tongue Announces Review of Strategic Alternatives Exhibit 99.1 Blonder Tongue Announces Review of Strategic Alternatives OLD BRIDGE, NJ / March 14, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that its Board of Directors has authorized a review of strategic alternatives for the Company aimed at enhancing stockholder value. Emerging Growth Equities, Ltd. has been engaged to serve as the exclusive financial advisor |
|
| March 4, 2022 |
Eighth Amendment to Loan Agreement, dated March 3, 2022 Exhibit 10.1 EIGHTH AMENDMENT TO LOAN AGREEMENT This EIGHTH AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made this as of the 3rd day of March, 2022 by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, ? |
|
| March 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| February 15, 2022 |
Seventh Amendment to Loan Agreement, dated February 11, 2022 Exhibit 10.1 SEVENTH AMENDMENT TO LOAN AGREEMENT This SEVENTH AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made this as of the day of February, 2022 by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, |
|
| February 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| January 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2022 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| December 17, 2021 |
Sixth Amendment to Loan Agreement, dated December 16, 2021. Exhibit 10.1 SIXTH AMENDMENT TO LOAN AGREEMENT This SIXTH AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made this as of the 16th day of December, 2021, and shall be retroactively effective as of December 15, 2021, by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware c |
|
| December 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction (Commission File Nu |
|
| December 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of (Commission File |
|
| December 14, 2021 |
BLONDER TONGUE EXECUTIVE DEFERRED COMPENSATION AGREEMENT Exhibit 99.1 BLONDER TONGUE EXECUTIVE DEFERRED COMPENSATION AGREEMENT THIS DEFERRED COMPENSATION AGREEMENT (?Agreement?) is made as of this day of December, 2021 (the ?Effective Date?), by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the ?Company?), and (the ?Executive?). WITNESSETH: WHEREAS, the Company and the Executive desire to defer payment of certain compensation ot |
|
| December 13, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Receipt of Notice of Delisting from NYSE American Common Stock Expected to Continue Trading on NYSE American During Appeal Process OLD BRIDGE, NJ / Friday, December 10, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced that it received notice today from NYSE American LLC (?NYSE American? or the ?Exchange?) stating t |
|
| December 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| November 15, 2021 |
Exhibit 10.1 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this ?Agreement?) made and entered into as of November 15, 2021, between Cavalry Fund I LP, 61 Kinderkamack Rd, Woodcliff Lake, NJ 07677 (hereinafter referred to as ?Buyer?) and Blonder Tongue Laboratories, Inc. (hereinafter referred to as ?Seller?). Background This Agreement sets forth the terms and conditions upon which Seller |
|
| November 15, 2021 |
425,000 Shares Blonder Tongue Laboratories, Inc. Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-254719 PROSPECTUS SUPPLEMENT (to Prospectus dated May 13, 2021) 425,000 Shares Blonder Tongue Laboratories, Inc. Common Stock We are offering 425,000 shares of our common stock at a price of $1.12 per share. Our common stock is traded on the NYSE American, under the symbol ?BDR.? On November 12, 2021, the closing sale price of our common stock |
|
| November 15, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| October 22, 2021 |
Blonder Tongue Announces Third Quarter and Nine- Month 2021 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Third Quarter and Nine- Month 2021 Results OLD BRIDGE, NJ / October 22, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the third quarter and nine months ended September 30, 2021. Blonder Tongue Laboratories, Inc. net sales increased $1,000 or 0.02% to $4,172,000 for the third quarter of |
|
| October 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021. OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE L |
|
| October 22, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction (Commission File Num |
|
| August 30, 2021 |
Fifth Amendment to Loan Agreement, dated August 26, 2021. Exhibit 10.1 FIFTH AMENDMENT TO LOAN AGREEMENT This FIFTH AMENDMENT TO LOAN AGREEMENT (this ?Amendment?) is made this as of the 26th day of August, 2021 by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, ? |
|
| August 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Co |
|
| August 30, 2021 |
Promissory Note dated August 24, 2021. Exhibit 10.2 CONFIDENTIAL TREATMENT [***] indicates that certain confidential information contained in this document, marked by brackets, has been omitted because the information is (i) not material and (ii) would be competitively harmful if publicly disclosed. PROMISSORY NOTE US $630,111.11 August 24th, 2021 For value received, the undersigned (?Maker?) promises and agrees to pay to [***], the pr |
|
| August 23, 2021 |
Exhibit 10.1 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this ?Agreement?) made and entered into as of August 23, 2021, between Cavalry Fund I LP, 61 Kinderkamack Rd, Woodcliff Lake, NJ 07677 (hereinafter referred to as "Buyer") and Blonder Tongue Laboratories, Inc. (hereinafter referred to as ?Seller?). This Agreement sets forth the terms and conditions upon which Seller is selling an |
|
| August 23, 2021 |
200,000 Shares Blonder Tongue Laboratories, Inc. Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-254719 PROSPECTUS SUPPLEMENT (to Prospectus dated May 13, 2021) 200,000 Shares Blonder Tongue Laboratories, Inc. Common Stock We are offering 200,000 shares of our common stock at a price of $1.08 per share. Our common stock is traded on the NYSE American, under the symbol “BDR.” On August 20, 2021, the closing sale price of our common stock on |
|
| August 23, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Co |
|
| August 16, 2021 |
$400,000 Blonder Tongue Laboratories, Inc. Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-254719 PROSPECTUS SUPPLEMENT (to Prospectus dated May 13, 2021) $400,000 Blonder Tongue Laboratories, Inc. Common Stock We have entered into a sales agreement, or the sales agreement, with Roth Capital Partners, LLC, or ?Roth Capital Partners? or the ?sales agent,? relating to the issuance and sale of our common stock offered by this prospectus |
|
| August 16, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Co |
|
| August 16, 2021 |
EX-1.1 2 ea145829ex1-1blonder.htm SALES AGREEMENT DATED AUGUST 16, 2021, BETWEEN BLONDER TONGUE LABORATORIES, INC. AND ROTH CAPITAL PARTNERS, LLC Exhibit 1.1 BLONDER TONGUE LABORATORIES, INC. $400,000 Common Stock ($0.001 par value per share) Sales Agreement August 16, 2021 Roth Capital Partners, LLC 888 San Clemente Drive, Suite 400 Newport Beach, CA 92660 Ladies and Gentlemen: Blonder Tongue Lab |
|
| August 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021. OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LABORA |
|
| August 12, 2021 |
Blonder Tongue Announces Second Quarter and Six Months 2021 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Second Quarter and Six Months 2021 Results OLD BRIDGE, NJ / August 12, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the second quarter and six months ended June 30, 2021. Blonder Tongue Laboratories, Inc. net sales increased $507,000 or 13.2% to $4,338,000 for the second quarter of 202 |
|
| August 12, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Co |
|
| August 2, 2021 |
Fourth Amendment to Loan Agreement, dated July 30, 2021. Exhibit 10.1 FOURTH AMENDMENT TO LOAN AGREEMENT This FOURTH AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made as of the 30th day of July, 2021 by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, ?Borro |
|
| August 2, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| July 6, 2021 |
Blonder Tongue Announces Forgiveness of CARES Act PPP Loan Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Forgiveness of CARES Act PPP Loan OLD BRIDGE, NJ / July 6, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it has received forgiveness of $1,768,762 of loan proceeds (?PPP Loan?) previously received under the Paycheck Protection Program (?PPP?). As previously disclosed, on April 10, 2020, the Company re |
|
| July 6, 2021 |
Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| June 21, 2021 |
Exhibit 99.1 BLONDER TONGUE LABS AND INNOVATIVE SYSTEMS ENABLE CURRENT AND LEGACY SMB AND HOSPITALITY VIDEO SYSTEMS FOR IP MULTICASTING NXG Platform with IP Multicast and OTT Unicast Significantly Reduces Operating Cost, Space and Time when SMB?s Upgrade their IP Video Offerings Old Bridge, N.J. ? June 16, 2021 ? Blonder Tongue Laboratories, Inc. (NYSE American: BDR), a leading US-based designer a |
|
| June 21, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| June 15, 2021 |
Third Amendment to Loan Agreement, effective as of June 14, 2021. Exhibit 10.1 THIRD AMENDMENT TO LOAN AGREEMENT This THIRD AMENDMENT TO LOAN AGREEMENT (this "Amendment") is made this 14th day of June, 2021 by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called ?Lender?), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, ?Borrower?), |
|
| June 15, 2021 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission File |
|
| May 27, 2021 |
Blonder Tongue Laboratories, Inc. Conflict Minerals Report For The Year Ended December 31, 2020 Exhibit 1.01 Blonder Tongue Laboratories, Inc. Conflict Minerals Report For The Year Ended December 31, 2020 This is the Conflict Minerals Report (?Report?) of Blonder Tongue Laboratories, Inc., a Delaware corporation, for the year ended December 31, 2020, which is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (the ?Rule?). The Rule was adopted by the Se |
|
| May 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized disclosure report Blonder Tongue Laboratories, Inc. (Exact name of Registrant as specified in its Charter) 1-14120 Commission file number Delaware 52-1611421 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification no.) One Jake Brown Road, Old Bridge, NJ 08857 (Address |
|
| May 26, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission File |
|
| May 19, 2021 |
Blonder Tongue Laboratories, Inc. 214,274 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration No. 333-254719 PROSPECTUS Blonder Tongue Laboratories, Inc. 214,274 Shares Common Stock The selling securityholders named in this prospectus may use this prospectus to offer and resell from time to time up to 214,274 shares of our common stock, par value $0.001 per shar, issuable by us upon the exercise of certain outstanding warrants to purchase share |
|
| May 13, 2021 |
Blonder Tongue Announces First Quarter 2021 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces First Quarter 2021 Results OLD BRIDGE, NJ / May 13, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the first quarter ended March 31, 2021. Blonder Tongue Laboratories, Inc. net sales decreased $799,000 or 19.7% to $3,251,000 for the first quarter of 2021 from $4,050,000 for the comparabl |
|
| May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021. OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LABOR |
|
| May 13, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission File |
|
| May 10, 2021 |
Blonder Tongue Laboratories, Inc. One Jake Brown Road Old Bridge, New Jersey 08857 May 10, 2021 Blonder Tongue Laboratories, Inc. One Jake Brown Road Old Bridge, New Jersey 08857 May 10, 2021 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Eiko Yaoita Pyles Re: Acceleration Request Blonder Tongue Laboratories, Inc. Registration Statement on Form S-3 Initially Filed March 25, 2021 File No. 333-254719 Ladies and Gentlemen: Pursuant to the requ |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission File N |
|
| April 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| April 19, 2021 |
As filed with the Securities and Exchange Commission on April 19, 2021 Registration No. |
|
| April 7, 2021 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 2, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission File |
|
| April 7, 2021 |
Blonder Tongue Announces Receipt of Noncompliance Notice from NYSE American Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Receipt of Noncompliance Notice from NYSE American OLD BRIDGE, NJ / April 7, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it has received notice from NYSE American LLC (?NYSE American?) that it is not in compliance with the continued listing standard set forth in Section 1003(a)(i) of the NYSE Americ |
|
| March 25, 2021 |
Exhibit 4.2 Blonder Tongue Laboratories, Inc. DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description summarizes the material terms and provisions of our common stock, which is registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (and is the only class of our securities that is |
|
| March 25, 2021 |
Subsidiaries of Blonder Tongue Exhibit 21 List of Subsidiaries of Blonder Tongue Laboratories, Inc. 1. Blonder Tongue Far East, LLC 2. R. L. Drake Holdings, LLC |
|
| March 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020, OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM to Commission file number: 1-14120 BLONDER TONGUE LABORATORIE |
|
| March 25, 2021 |
As filed with the Securities and Exchange Commission on March 25, 2021 Registration No. |
|
| March 12, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission Fil |
|
| March 12, 2021 |
Blonder Tongue Reports Fourth Quarter and Year End 2020 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Fourth Quarter and Year End 2020 Results OLD BRIDGE, NJ / March 12, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the fourth quarter and year ended December 31, 2020. Commenting on the year end and fourth quarter results, Chief Executive Officer Ted Grauch noted, ?Faced with a very diffic |
|
| March 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| March 11, 2021 |
Omnibus Amendment to Non-Qualified Stock Option Agreements. Exhibit 10.1 BLONDER TONGUE LABORATORIES, INC. ROBERT J. PALL? OMNIBUS AMENDMENT OF NON-QUALIFIED STOCK OPTION AGREEMENTS THIS OMNIBUS AMENDMENT OF NON-QUALIFIED STOCK OPTION AGREEMENTS (?Omnibus Amendment?) is made and entered into on the 11th day of March, 2021 (the ?Effective Date?), by and between BLONDER TONGUE LABORATORIES, INC. a Delaware corporation (the ?Company?) and Robert J. Pall? (the |
|
| March 5, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction (Commission File Number |
|
| February 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| February 11, 2021 |
Blonder Tongue Laboratories, Inc. 2,752,323 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration No. 333-252718 PROSPECTUS Blonder Tongue Laboratories, Inc. 2,752,323 Shares Common Stock The selling securityholders named in this prospectus may use this prospectus to offer and resell from time to time up to 2,752,323 shares (the “Shares”) of our common stock, par value $0.001 per share (“Common Stock”) issuable by us upon conversion of subordinated |
|
| February 10, 2021 |
Schedule 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Blonder Tongue Laboratories, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 093698 108 (CUSIP Number) January 26, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 8, 2021 |
Blonder Tongue Laboratories, Inc. One Jake Brown Road Old Bridge, New Jersey 08857 February 8, 2021 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Effie Simpson Re: Acceleration Request Blonder Tongue Laboratories, Inc. Registration Statement on Form S-3 Filed February 4, 2021 File No. 333-252718 Ladies and Gentlemen: Pursuant to the requirements |
|
| February 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| February 4, 2021 |
As filed with the Securities and Exchange Commission on February 4, 2021 Registration No. |
|
| February 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission F |
|
| February 1, 2021 |
Exhibit 10.1 EXECUTION COPY THIRD Amendment to SENIOR SUBORDINATED CONVERTIBLE LOAN AND SECURITY AGREEMENT AND JOINDER This Third Amendment to Senior Subordinated Convertible Loan and Security Agreement and Joinder (this “Third Amendment”), dated as of January 28, 2021 (the “Third Amendment Effective Date”), is among Blonder Tongue Laboratories, Inc., a Delaware corporation (the “Company”), the se |
|
| February 1, 2021 |
Form of Placement Agent Common Stock Purchase Warrant. Exhibit 4.1 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK UNDERLYING THIS WARRANT OF BLONDER TONGUE LABORATORIES, INC. (THE “COMPANY”) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY A |
|
| January 22, 2021 |
Blonder Tongue Laboratories, Inc. 2,142,857 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration No. 333-252088 PROSPECTUS Blonder Tongue Laboratories, Inc. 2,142,857 Shares Common Stock The selling stockholders named in this prospectus may use this prospectus to offer and resell from time to time up to 2,142,857 shares of our common stock, par value $0.001 per share (“Common Stock”), comprised of (i) 1,428,571 shares of our Common Stock (the “Sha |
|
| January 19, 2021 |
Blonder Tongue Laboratories, Inc. One Jake Brown Road Old Bridge, New Jersey 08857 January 19, 2021 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Erin Purnell Re: Acceleration Request Blonder Tongue Laboratories, Inc. Registration Statement on Form S-3 Filed January 14, 2021 File No. 333-252088 Ladies and Gentlemen: Pursuant to the requirements |
|
| January 14, 2021 |
Warrant to VFT Special Ventures, Ltd. EX-4.2 2 ea132916ex4-2blonder.htm WARRANT TO VFT SPECIAL VENTURES, LTD. Exhibit 4.2 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK UNDERLYING THIS WARRANT OF BLONDER TONGUE LABORATORIES, INC. (THE “COMPANY”) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR TRANSFERRED UNTIL (i) A REGISTRA |
|
| January 14, 2021 |
As filed with the Securities and Exchange Commission on January 13, 2021 Registration No. |
|
| January 11, 2021 |
Second Amendment to Loan Agreement, Dated as of January 8, 2021. EX-10.1 2 ea133126ex10-1blonder.htm SECOND AMENDMENT TO LOAN AGREEMENT, DATED AS OF JANUARY 8, 2021 Exhibit 10.1 SECOND AMENDMENT TO LOAN AGREEMENT This SECOND AMENDMENT TO LOAN AGREEMENT (this “Amendment”) is made this 8th day of January, 2021 by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called “Lender”), BLONDER TONGUE LABOR |
|
| January 11, 2021 |
Form of Deferred Compensation Agreement. Exhibit 10.2 THIS DEFERRED COMPENSATION AGREEMENT (“Agreement”) is made as of this day of January, 2021 (the “Effective Date”), by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the “Company”), and (the “Executive”). WITNESSETH: WHEREAS, the Company and the Executive desire to defer payment of certain compensation otherwise payable by the Company to the Executive. NOW, THER |
|
| January 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2021 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Co |
|
| December 30, 2020 |
Deferred Compensation Agreement, Dated as of December 30, 2020. EX-10.1 2 ea132457ex10-1blondertongue.htm DEFERRED COMPENSATION AGREEMENT, DATED AS OF DECEMBER 30, 2020 Exhibit 10.1 THIS DEFERRED COMPENSATION AGREEMENT (“Agreement”) is made as of this 30th day of December, 2020 (the “Effective Date”), by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the “Company”), and EDWARD R. GRAUCH (the “Executive”). W I T N E S S E T H: WHEREAS, t |
|
| December 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| December 29, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| December 29, 2020 |
Exhibit 10.1 SECOND Amendment to SENIOR SUBORDINATED CONVERTIBLE LOAN AND SECURITY AGREEMENT This Second Amendment to Senior Subordinated Convertible Loan and Security Agreement (this “Second Amendment”), dated as of December 28, 2020 (the “Second Amendment Effective Date”), is among Blonder Tongue Laboratories, Inc., a Delaware corporation (the “Company”), the several Persons party to this Amendm |
|
| December 28, 2020 |
Schedule 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Blonder Tongue Laboratories, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 093698 108 (CUSIP Number) December 14, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| December 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| December 16, 2020 |
Form of Purchaser Common Stock Purchase Warrant. Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| December 16, 2020 |
Blonder Tongue Announces Signing of Securities Purchase Agreement for Private Placement Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Signing of Securities Purchase Agreement for Private Placement OLD BRIDGE, NJ / December 15, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) (the “Company”) today announced that it has entered into a Securities Purchase Agreement with certain accredited investors for the sale of shares of its common stock, $0.001 par value |
|
| December 16, 2020 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 14, 2020, between Blonder Tongue Laboratories, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms |
|
| December 16, 2020 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 14, 2020, between Blonder Tongue Laboratories, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursuant to the Secur |
|
| December 16, 2020 |
Form of Placement Agent Contingent Common Stock Purchase Warrant. Exhibit 4.3 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK UNDERLYING THIS WARRANT OF BLONDER TONGUE LABORATORIES, INC. (THE “COMPANY”) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY A |
|
| December 16, 2020 |
Form of Placement Agent Common Stock Purchase Warrant. Exhibit 4.2 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK UNDERLYING THIS WARRANT OF BLONDER TONGUE LABORATORIES, INC. (THE “COMPANY”) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY A |
|
| December 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| December 10, 2020 |
Blonder Tongue Announces Receipt of Noncompliance Notice from NYSE American Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Receipt of Noncompliance Notice from NYSE American OLD BRIDGE, NJ / December 10, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it has received notice from NYSE American LLC (?NYSE American?) that it is not in compliance with the continued listing standard set forth in Section 1003(a)(ii) of the NYSE A |
|
| November 12, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE L |
|
| November 12, 2020 |
Amendment No. 2 to 2016 Director Equity Incentive Plan. Exhibit 10.6 AMENDMENT No. 2 to BLONDER TONGUE LABORATORIES, INC. 2016 DIRECTOR EQUITY INCENTIVE PLAN This Amendment No. 2 (“Amendment”) to Blonder Tongue Laboratories, Inc. 2016 Director Equity Incentive Plan (the “Plan”) has been adopted and approved by the Board of Directors on October 12, 2020, and shall be effective as of such date. By this Amendment, the original text of the defined term “Fa |
|
| November 12, 2020 |
Amendment No. 1 to Third Amended and Restated Director Stock Purchase Plan. Exhibit 10.5 AMENDMENT No. 1 to BLONDER TONGUE LABORATORIES, INC. THIRD AMENDED AND RESTATED DIRECTOR STOCK PURCHASE PLAN This Amendment No. 1 (“Amendment”) to Blonder Tongue Laboratories, Inc. Third Amended and Restated Director Stock Purchase Plan (the “Plan”) has been adopted and approved by the Board of Directors on October 12, 2020, and shall be effective as of such date. By this Amendment, t |
|
| November 12, 2020 |
Third Amended and Restated Director Stock Purchase Plan. Exhibit 10.4 As adopted by the Board of Directors on August 6, 2020, retroactively effective as of July 1, 2020 THIRD AMENDED AND RESTATED DIRECTOR STOCK PURCHASE PLAN The purpose of this Third Amended and Restated Director Stock Purchase Plan (the “Plan”) is to provide an opportunity for non-employee Directors of Blonder Tongue Laboratories, Inc. (the “Company”) to purchase Common Stock of the Co |
|
| November 12, 2020 |
Amendment No. 3 to 2016 Employee Equity Incentive Plan. Exhibit 10.7 AMENDMENT No. 3 to BLONDER TONGUE LABORATORIES, INC. 2016 EMPLOYEE EQUITY INCENTIVE PLAN This Amendment No. 3 (“Amendment”) to Blonder Tongue Laboratories, Inc. 2016 Employee Equity Incentive Plan (the “Plan”) has been adopted and approved by the Board of Directors on October 12, 2020, and shall be effective as of such date. By this Amendment, the original text of the defined term “Fa |
|
| October 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) |
|
| October 14, 2020 |
Second Amended and Restated Executive Stock Purchase Plan. Exhibit 10.1 As adopted by the Board of Directors on September 10, 2020, retroactively effective as of September 1, 2020. SECOND AMENDED AND RESTATED EXECUTIVE STOCK PURCHASE PLAN The purpose of this Second Amended and Restated Executive Stock Purchase Plan (the “Plan”) is to provide an opportunity for Executives of Blonder Tongue Laboratories, Inc. (the “Company”) to purchase Common Stock of the |
|
| October 14, 2020 |
Amendment No. 1 Second Amended and Restated Executive Stock Purchase Plan. Exhibit 10.2 AMENDMENT No. 1 to BLONDER TONGUE LABORATORIES, INC. SECOND AMENDED AND RESTATED EXECUTIVE STOCK PURCHASE PLAN This Amendment No. 1 (“Amendment”) to Blonder Tongue Laboratories, Inc. Second Amended and Restated Director Stock Purchase Plan (the “Plan”) has been adopted and approved by the Board of Directors on October 12, 2020, and shall be effective as of such date. By this Amendment |
|
| October 13, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| October 13, 2020 |
Blonder Tongue Announces U.S. Patent Grant for its Networking Modules for Display Systems Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces U.S. Patent Grant for its Networking Modules for Display Systems OLD BRIDGE, NJ / October 13, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) is pleased to report that the US Patent and Trademark Office (USPTO) has issued a patent, US10,805,660, for certain technologies within Blonder Tongue’s DOCSIS Data (DMM) series of pr |
|
| October 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission |
|
| September 23, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) |
|
| September 23, 2020 |
Blonder Tongue Announces U.S. Patent Grant for its NXG Video Delivery Platform Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces U.S. Patent Grant for its NXG Video Delivery Platform OLD BRIDGE, NJ / September 23, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) is pleased to report that the US Patent and Trademark Office (USPTO) has issued the patent, US10,785,829, for certain technologies within Blonder Tongue’s NeXgen Gateway (NXG) video delivery p |
|
| September 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| September 4, 2020 |
Form of Deferred Compensation Agreement for certain Executive Officers. Exhibit 10.1 THIS DEFERRED COMPENSATION AGREEMENT (“Agreement”) is made as of this day of , 2020 (the “Effective Date”), by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the “Company”), and (the “Executive”). WITNESSETH: WHEREAS, the Company and the Executive desire to defer payment of certain compensation otherwise payable by the Company to the Executive. NOW, THEREFORE, |
|
| September 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Co |
|
| September 2, 2020 |
Blonder Tongue Announces Acceptance of Compliance Plan by NYSE Regulation Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Acceptance of Compliance Plan by NYSE Regulation OLD BRIDGE, NJ / September 2, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) today announced that it has received notice from NYSE Regulation that it has accepted the Company’s plan to regain compliance with the NYSE American LLC (“NYSE American”) continuing listing standard |
|
| August 20, 2020 |
Blonder Tongue Comments on Recent Common Stock Trading Activity Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Comments on Recent Common Stock Trading Activity OLD BRIDGE, NJ / August 19, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) commented today on recent trading activity in the Company’s common stock. Blonder Tongue knows of no reason for the recent increase in the price and trading volume of its stock. There have been no material deve |
|
| August 20, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction (Commission File Numb |
|
| August 20, 2020 |
Blonder Tongue Comments on Continuing Cost Reduction Activities Exhibit 99.2 FOR IMMEDIATE RELEASE: Blonder Tongue Comments on Continuing Cost Reduction Activities OLD BRIDGE, NJ / August 20, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) commented today on its continuing efforts to reduce its costs and conserve its working capital and liquidity. While the Company has indicated that there have been no material developments or change in circumsta |
|
| August 13, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2020. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LABORA |
|
| August 11, 2020 |
Blonder Tongue Announces Appointment of Rick Briggs as Director Exhibit 99.1 One Jake Brown Road Old Bridge, NJ 08857 Tel: 732-679-4000 Fax: 732-679-4353 www.blondertongue.com FOR IMMEDIATE RELEASE: Blonder Tongue Announces Appointment of Rick Briggs as Director OLD BRIDGE, New Jersey—August 11, 2020—Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today the appointment of Rick Briggs to its board of directors. Mr. Briggs is a highly experience |
|
| August 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| August 7, 2020 |
Blonder Tongue Reports Second Quarter 2020 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Second Quarter 2020 Results OLD BRIDGE, NJ / August 7, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the second quarter and six months ended June 30, 2020. Net sales decreased $1,606,000 or 29.5% to $3,831,000 for the second quarter of 2020 from $5,437,000 for the comparable period in 201 |
|
| August 7, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| June 16, 2020 |
Blonder Tongue Announces Receipt of Noncompliance Notice from NYSE American Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Receipt of Noncompliance Notice from NYSE American OLD BRIDGE, NJ / June 16, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it has received notice from NYSE American LLC (“NYSE American”) that it is not in compliance with the continued listing standard set forth in Section 1003(a)(iii) of the NYSE Amer |
|
| June 16, 2020 |
Blonder Tongue Announces Appointment of Michael Hawkey as Director Exhibit 99.2 One Jake Brown Road Old Bridge, NJ 08857 Tel: 732-679-4000 Fax: 732-679-4353 www.blondertongue.com FOR IMMEDIATE RELEASE: Blonder Tongue Announces Appointment of Michael Hawkey as Director OLD BRIDGE, New Jersey—June 15, 2020—Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today the appointment of Michael Hawkey to its board of directors. Mr. Hawkey is a highly experi |
|
| June 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| May 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized disclosure report Blonder Tongue Laboratories, Inc. (Exact name of Registrant as specified in its Charter) 1-14120 Commission file number Delaware 52-1611421 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification no.) One Jake Brown Road, Old Bridge, NJ 08857 (Address |
|
| May 29, 2020 |
Conflict Minerals Report of the Company Exhibit 1.01 Blonder Tongue Laboratories, Inc. Conflict Minerals Report For The Year Ended December 31, 2019 This is the Conflict Minerals Report (“Report”) of Blonder Tongue Laboratories, Inc., a Delaware corporation, for the year ended December 31, 2019, which is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (the “Rule”). The Rule was adopted by the Se |
|
| May 26, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commi |
|
| May 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction (Commission File Number) |
|
| May 19, 2020 |
Form of Deferred Compensation Agreement for certain Executive Officers. Exhibit 10.1 THIS DEFERRED COMPENSATION AGREEMENT (“Agreement”) is made as of this 3rd day of May, 2020 (the “Effective Date”), by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the “Company”), and (the “Executive”). WITNESSETH: WHEREAS, the Company and the Executive desire to defer payment of certain compensation otherwise payable by the Company to the Executive. NOW, THER |
|
| May 15, 2020 |
Blonder Tongue Reports First Quarter 2020 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports First Quarter 2020 Results OLD BRIDGE, NJ / May 15, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the first quarter ended March 31, 2020. Net sales decreased $32,000 or 0.8% to $4,050,000 for the first quarter of 2020 from $4,082,000 for the comparable period in 2019. Net loss for the thr |
|
| May 15, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction (Commission File Number) |
|
| May 15, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2020. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LABOR |
|
| May 12, 2020 |
- DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| May 12, 2020 |
Annual Report - AMENDMENT NO. 1 TO FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019, OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM to Commission file number: 1-14120 BLONDE |
|
| May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| April 27, 2020 |
Exhibit 10.1 EXECUTION COPY first Amendment to SENIOR SUBORDINATED CONVERTIBLE LOAN AND SECURITY AGREEMENT AND JOINDER This First Amendment to Senior Subordinated Convertible Loan and Security Agreement and Joinder (this “First Amendment”), dated as of April 24, 2020 (the “First Amendment Effective Date”), is among Blonder Tongue Laboratories, Inc., a Delaware corporation (the “Company”), the seve |
|
| April 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| April 27, 2020 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| April 13, 2020 |
Subsidiaries of Blonder Tongue Exhibit 21 List of Subsidiaries of Blonder Tongue Laboratories, Inc. 1. Blonder Tongue Far East, LLC 2. R. L. Drake Holdings, LLC |
|
| April 13, 2020 |
BDR / Blonder Tongue Laboratories, Inc. 10-K - Annual Report - ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019, OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM to Commission file number: 1-14120 BLONDER TONGUE LABORATORIE |
|
| April 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| April 13, 2020 |
Blonder Tongue Announces Receipt of Loan Proceeds Under Paycheck Protection Program Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Receipt of Loan Proceeds Under Paycheck Protection Program OLD BRIDGE, NJ / April 13, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it has received loan proceeds of $1,768,762 (“PPP Loan”) under the Paycheck Protection Program (“PPP”). The PPP, established as part of the Coronavirus Aid, Relief and Ec |
|
| April 9, 2020 |
Exhibit 10.4 EXECUTION COPY CONTINUING GUARANTY April 8, 2020 TO: ROBERT J. PALLÉ, as Agent on behalf of the Lenders 1. GUARANTY; DEFINITIONS. In consideration of any credit or other financial accommodation heretofore, now or hereafter extended or made to BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, “Borrower”) by Livewire Ventures, |
|
| April 9, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| April 9, 2020 |
Exhibit 10.2 CONSENT AND AMENDMENT TO LOAN AGREEMENT AND LOAN DOCUMENTS This CONSENT AND AMENDMENT TO LOAN AGREEMENT AND LOAN DOCUMENTS (this “Amendment”) is made this 7th day of April, 2020 by and among MidCap Business Credit LLC, a Texas limited liability company, the secured party hereunder (hereinafter called “Lender”), BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with i |
|
| April 9, 2020 |
Exhibit 10.3 SUBORDINATION AGREEMENT THIS SUBORDINATION AGREEMENT, dated as of April 8, 2020, is by and between MIDCAP BUSINESS CREDIT LLC, a Texas limited liability company, as the Senior Lender (as defined below) under the Senior Loan Documents (as defined below), and the Junior Creditor under the Junior Debt Documents (as each term is defined below), and is acknowledged by, BLONDER TONGUE LABOR |
|
| April 9, 2020 |
Exhibit 10.1 FINAL EXECUTON COPY THIS SENIOR SUBORDINATED CONVERTIBLE LOAN AND SECURITY AGREEMENT AND THE INDEBTEDNESS EVIDENCED HEREBY ARE SUBORDINATED IN THE MANNER AND TO THE EXTENT SET FORTH IN THAT CERTAIN SUBORDINATION AGREEMENT OF EVEN DATE HEREWITH AMONG MIDCAP BUSINESS CREDIT LLC, THE LENDERS, AND ROBERT J. PALLÉ, AS AGENT FOR THE LENDERS (AS AMENDED, RESTATED, SUPPLEMENTED OR OTHERWISE M |
|
| April 9, 2020 |
Exhibit 10.5 Execution Copy PATENT AND TRADEMARK SECURITY AGREEMENT This Patent and Trademark Security Agreement (this “Agreement”), dated as of April 8, 2020, is made by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, “Parent”), R. L. DRAKE HOLDINGS, LLC, a Delaware limited liability company (together with its permitted su |
|
| April 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| April 9, 2020 |
Blonder Tongue Reports Fourth Quarter and Year End 2019 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Fourth Quarter and Year End 2019 Results OLD BRIDGE, NJ / April 9, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the fourth quarter and year ended December 31, 2019. Net sales decreased $396,000 or 7.3% to $5,045,000 for the fourth quarter of 2019 from $5,441,000 for the comparable period |
|
| April 9, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Announces Successful Closing of $800,000 Subordinated Convertible Debt Financing and Amendment of MidCap Loan Facility OLD BRIDGE, NJ / April 9, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it has entered into a definitive Senior Subordinated Convertible Loan and Security Agreement (the “Loan Agreement”) with |
|
| March 26, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| March 26, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Postpones Conference Call to Discuss Fourth Quarter and Full Year 2019 Earnings Results OLD BRIDGE, NJ / March 26, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it is postponing its previously announced release of its fourth quarter and fiscal 2019 earnings results, originally scheduled for Friday, March 27, 20 |
|
| January 27, 2020 |
Blonder Tongue Announces Appointment of John Burke as Director Exhibit 99.1 One Jake Brown Road Old Bridge, NJ 08857 Tel: 732-679-4000 Fax: 732-679-4353 www.blondertongue.com FOR IMMEDIATE RELEASE: Blonder Tongue Announces Appointment of John Burke as Director OLD BRIDGE, New Jersey—January 27, 2020—Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced today the appointment of John Burke to its board of directors. Mr. Burke is a seasoned senior oper |
|
| January 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2020 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of (Commission File |
|
| January 6, 2020 |
Exhibit 10.1 THIS DEFERRED COMPENSATION AGREEMENT (“Agreement”) is made as of this 29th day of December, 2019 (the “Effective Date”), by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the “Company”), and EDWARD R. GRAUCH (the “Executive”). W I T N E S S E T H: WHEREAS, the Company and the Executive desire to defer payment of certain compensation otherwise payable by the Com |
|
| January 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) ( |
|
| December 26, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction (Commission File Nu |
|
| December 26, 2019 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Promotes Edward R. “Ted” Grauch to Chief Executive Officer – Retains Role as President OLD BRIDGE, New Jersey—December 26, 2019—Blonder Tongue Laboratories, Inc. (NYSE American: BDR) (the “Company”) announced that the Company’s Board of Directors has promoted Edward R. “Ted” Grauch to Chief Executive Officer of the Company, effective January 1, 20 |
|
| November 8, 2019 |
BDR / Blonder Tongue Laboratories, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE L |
|
| November 6, 2019 |
Blonder Tongue Reports Third Quarter 2019 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Third Quarter 2019 Results OLD BRIDGE, NJ / November 6, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the third quarter and nine months ended September 30, 2019. Net sales decreased $348,000 or 6.2% to $5,278,000 for the third quarter of 2019 from $5,626,000 for the comparable period in 2 |
|
| November 6, 2019 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| October 30, 2019 |
Exhibit 10.3 PLEDGE AND SECURITY AGREEMENT Pledge and Security Agreement (“Agreement”) made and entered into as of the 25th day of October, 2019 by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the “Pledgor”) and MIDCAP BUSINESS CREDIT LLC (the “Secured Party”), having an address at 433 South Main Street, West Hartford, Connecticut 06110. W I T N E S S E T H: WHEREAS, Pled |
|
| October 30, 2019 |
Exhibit 10.2 MIDCAP BUSINESS CREDIT LLC REVOLVING NOTE $5,000,000.00 October 25, 2019 West Hartford, Connecticut For value received, the undersigned BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (the “Borrower”), hereby promises to pay in accordance with the Loan Agreement (defined below), to the order of MidCap Business Credit LLC, a Texas limited liability company (the “Lender”), at |
|
| October 30, 2019 |
Exhibit 10.4 PATENT AND TRADEMARK SECURITY AGREEMENT This Patent and Trademark Security Agreement (this “Agreement”), dated as of October 25, 2019, is made by and between BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, “Parent”), R. L. DRAKE HOLDINGS, LLC, a Delaware limited liability company (together with its permitted successors and |
|
| October 30, 2019 |
Exhibit 10.5 CONTINUING GUARANTY October 25, 2019 TO: MIDCAP BUSINESS CREDIT LLC 1. GUARANTY; DEFINITIONS. In consideration of any credit or other financial accommodation heretofore, now or hereafter extended or made to BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (together with its successors and permitted assigns, “Parent”), (the “Borrower”) by MIDCAP BUSINESS CREDIT LLC ("MidCap"), |
|
| October 30, 2019 |
Blonder Tongue Labs Obtains $5,000,000 Revolving Credit Facility from MidCap Business Credit Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Labs Obtains $5,000,000 Revolving Credit Facility from MidCap Business Credit Old Bridge, NJ / October 30, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) (the “Company”) announced that on October 25, 2019 it consummated a $5,000,000 financing transaction with MidCap Business Credit. The new credit facility consists of a $5,000,000 r |
|
| October 30, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| October 30, 2019 |
Exhibit 10.1 MIDCAP BUSINESS CREDIT LLC LOAN AND SECURITY AGREEMENT (ALL ASSETS) October 25, 2019 THIS LOAN AND SECURITY AGREEMENT (ALL ASSETS) (as amended or modified from time to time, this “Agreement”), is entered into as of the date set forth above by and between MIDCAP BUSINESS CREDIT LLC, a Texas limited liability company, the secured party hereunder (hereinafter called “Lender”), BLONDER TO |
|
| September 23, 2019 |
Third Amendment To Loan and Security Agreement dated as of September 19, 2019. Exhibit 10.1 THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”) is executed and entered into as of September 19, 2019 and effective as of the Effective Date, by and among BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (“Parent”), R. L. DRAKE HOLDINGS, LLC, a Delaware limited liability company (“Drake”, and together with |
|
| September 23, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) |
|
| August 14, 2019 |
BDR / Blonder Tongue Laboratories, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2019. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LABORA |
|
| August 14, 2019 |
Blonder Tongue Reports Second Quarter 2019 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Second Quarter 2019 Results OLD BRIDGE, NJ / August 14, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the second quarter and six months ended June 30, 2019. Net sales increased $160,000 or 3.0% to $5,437,000 for the second quarter of 2019 from $5,277,000 for the comparable period in 2018. |
|
| August 14, 2019 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Co |
|
| June 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commi |
|
| June 4, 2019 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Promotes Edward R. “Ted” Grauch to President – Retains Role as Chief Operating Officer OLD BRIDGE, New Jersey—June 4, 2019—Blonder Tongue Laboratories, Inc. (NYSE American: BDR) (the “Company”) announced that the Company’s Board of Directors has promoted Edward R. “Ted” Grauch to President of the Company, effective immediately. Mr. Grauch will als |
|
| May 28, 2019 |
BDR / Blonder Tongue Laboratories, Inc. SD - - SPECIALIZED DISCLOSURE REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized disclosure report Blonder Tongue Laboratories, Inc. (Exact name of Registrant as specified in its Charter) 1-14120 Commission file number Delaware 52-1611421 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification no.) One Jake Brown Road, Old Bridge, NJ 08857 (Address |
|
| May 28, 2019 |
Conflict Minerals Report of the Company Exhibit 1.01 Blonder Tongue Laboratories, Inc. Conflict Minerals Report For The Year Ended December 31, 2018 This is the Conflict Minerals Report (“Report”) of Blonder Tongue Laboratories, Inc., a Delaware corporation, for the year ended December 31, 2018, which is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (the “Rule”). The Rule was adopted by the Se |
|
| May 15, 2019 |
Blonder Tongue Reports First Quarter 2019 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports First Quarter 2019 Results OLD BRIDGE, NJ / May 15, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the first quarter ended March 31, 2019. Net sales decreased $1,281,000 or 23.9% to $4,082,000 for the first quarter of 2019 from $5,363,000 for the comparable period in 2018. Operating loss w |
|
| May 15, 2019 |
BDR / Blonder Tongue Laboratories, Inc. 10-Q Quarterly Report QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2019. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE LABOR |
|
| May 15, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Commi |
|
| May 2, 2019 |
BDR / Blonder Tongue Laboratories, Inc. / Williams James H /nj/ Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Blonder Tongue Laboratories, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 093698108 (CUSIP Number) James H. Williams c/o Blonder Tongue Laboratories, Inc. One Jake Brown Road Old Bridge, New Jersey 08857 (7 |
|
| April 18, 2019 |
BDR / Blonder Tongue Laboratories, Inc. DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| April 2, 2019 |
Second Amendment To Loan and Security Agreement dated March 29, 2019. EX-10.1 2 f8k032919ex10-1blonder.htm SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT DATED MARCH 29, 2019 Exhibit 10.1 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”) is executed and entered into as of March 29, 2019 and effective as of the Effective Date, by and among BLONDER TONGUE LABORATORIES, INC., a Delaware corporation |
|
| April 2, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2019 Blonder Tongue Laboratories, Inc. (Exact name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Com |
|
| April 1, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission File |
|
| April 1, 2019 |
Blonder Tongue Reports Fourth Quarter and Year End 2018 Results Exhibit 99.1 FOR IMMEDIATE RELEASE: Blonder Tongue Reports Fourth Quarter and Year End 2018 Results OLD BRIDGE, NJ / April 1, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the fourth quarter and year ended December 31, 2018. Net sales decreased $129,000 or 2.3% to $5,441,000 for the fourth quarter of 2018 from $5,570,000 for the comparable period |
|
| April 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018, OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM to Commission file number: 1-14120 BLONDER TONGUE LABORATORIE |
|
| April 1, 2019 |
Subsidiaries of Blonder Tongue EXHIBIT 21 List of Subsidiaries of Blonder Tongue Laboratories, Inc. 1. Blonder Tongue Far East, LLC 2. R. L. Drake Holdings, LLC |
|
| February 14, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-14120 (Commission |
|
| February 6, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2018 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Comm |
|
| February 6, 2019 |
Debt Conversion and Lien Termination Agreement dated as of January 24, 2019. Exhibit 10.2 DEBT CONVERSION AND LIEN TERMINATION AGREEMENT This Debt Conversion and Lien Termination Agreement (this “Agreement”) is made and entered into as of January 24, 2019 by and among by and between Blonder Tongue Laboratories, Inc., a Delaware corporation (the “Company”), R.L. Drake Holdings, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company (“Drake” and |
|
| February 6, 2019 |
Consent Under Loan and Security Agreement dated February 1, 2019. Exhibit 10.1 CONSENT UNDER LOAN AND SECURITY AGREEMENT This CONSENT UNDER LOAN AND SECURITY AGREEMENT (this “Consent”) is dated as of February 1, 2019, and is entered into by and among BLONDER TONGUE LABORATORIES, INC., a Delaware corporation (“Parent”), R. L. DRAKE HOLDINGS, LLC, a Delaware limited liability company (“Drake”, together with Parent, collectively the “Borrowers”), BLONDER TONGUE FAR |
|
| January 31, 2019 |
Third Amendment to Agreement of Sale dated January 30, 2019. EX-10.1 2 f8k013019ex10-1blonder.htm THIRD AMENDMENT TO AGREEMENT OF SALE DATED JANUARY 30, 2019 Exhibit 10.1 THIRD AMENDMENT TO AGREEMENT OF SALE THIS THIRD AMENDMENT TO AGREEMENT OF SALE (“Third Amendment”), is made and entered into on this 30th day of January, 2019, by and between BLONDER TONGUE LABORATORIES, INC., as Seller and JAKE BROWN RD, LLC, as Buyer. Background A. Seller and Buyer enter |
|
| January 31, 2019 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (C |
|
| January 4, 2019 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 2, 2019 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 (State or other jurisdiction of incorporation) (Co |
|
| December 20, 2018 |
Exhibit 4.8 BLONDER TONGUE LABORATORIES, INC. NONQUALIFIED STOCK OPTION AGREEMENT THIS AGREEMENT is made and entered into as of the 16th day of August, 2018 (the “Grant Date”), by and between BLONDER TONGUE LABORATORIES, INC. a Delaware corporation (the “Company”), and Ronald Alterio (the “Optionee”). Background The Optionee is a key employee of the Company and possesses knowledge, experience and |
|
| December 20, 2018 |
BDR / Blonder Tongue Laboratories, Inc. REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on December 20, 2018 Registration No. |
|
| December 20, 2018 |
Exhibit 4.9 BLONDER TONGUE LABORATORIES, INC. NONQUALIFIED STOCK OPTION AGREEMENT THIS AGREEMENT is made and entered into as of the 29th day of October, 2018 (the “Grant Date”), by and between BLONDER TONGUE LABORATORIES, INC. a Delaware corporation (the “Company”), and Edward R. Grauch (the “Optionee”). Background The Optionee is a key employee of the Company and possesses knowledge, experience a |
|
| November 14, 2018 |
Letter Agreement between Blonder Tongue Laboratories, Inc. and Ronald V. Alterio. Exhibit 10.1 One Jake Brown Road Old Bridge, New Jersey 08857 Tel: 732-679-4000 Fax: 732-679-4353 www.blondertongue.com June 29, 2018 Mr. Ronald Alterio 501 Aylesbury Lane Delray Beach, FL 33444 Dear Ron: This letter supersedes and replaces our prior letter to you dated June 28, 2018. On behalf of Blonder Tongue Laboratories, Inc. (the “Company”), I am pleased to offer you employment with our Comp |
|
| November 14, 2018 |
BDR / Blonder Tongue Laboratories, Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2018. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission file number 1-14120 BLONDER TONGUE L |
|
| October 30, 2018 |
8-K 1 f8k103018blondertongue.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2018 Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) Delaware 1-14120 52-1611421 ( |
|
| October 30, 2018 |
Blonder Tongue Appoints Edward R. “Ted” Grauch as Executive Vice President & Chief Operating Officer Exhibit 99.1 One Jake Brown Road, Old Bridge NJ 08857 Phone: 732-679-4000 | Fax: 732-679-4353 www.blondertongue.com | www.rldrake.com FOR IMMEDIATE RELEASE: Blonder Tongue Appoints Edward R. “Ted” Grauch as Executive Vice President & Chief Operating Officer OLD BRIDGE, NJ / October 30, 2018 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced that the Company’s Board of Directors has |
